Functional neuroimaging methods hold promise for elucidating the neurobiolo
gy of autistic disorders, yet they present difficult practical and scientif
ic challenges when applied to these complex and heterogeneous syndromes. Si
ngle-state studies of brain metabolism and blood flow thus far have failed
to yield consistent findings, but suggest considerable variability in regio
nal patterns of cerebral synaptic activity. Patients with idiopathic autism
are less likely to show abnormalities than are patients with comorbid illn
ess or epilepsy. Activation studies have begun to suggest alterations in br
ain organization for language and cognition. Neurotransmitter studies using
positron emission tomography (PET) suggest abnormalities of serotonergic a
cid dopaminergic function. Studies using magnetic resonance spectroscopy (M
RS) have begun to document metabolic deficits in the frontal cortex and cer
ebellum. A single study using magnetoencephalography suggests a high incide
nce of epileptiform activity in children with autistic regression. Research
needs include well-controlled developmental studies, particularly of young
subjects and relatively homogeneous subgroups, which balance scientific ri
gor with ethical constraints. Investigations of the serotonergic and dopami
nergic systems, limbic-based memory and emotional systems, and the role of
epileptiform activity in autism represent priorities for future research. P
ublished 2000 Wiley-Liss, Inc.(dagger)